ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,476 Cr | ₹5,902 Cr | ₹5,178 Cr | ₹4,539 Cr | ₹4,207 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹6,476 Cr |
| Mar2025 | ₹5,902 Cr |
| Mar2024 | ₹5,178 Cr |
| Mar2023 | ₹4,539 Cr |
| Mar2022 | ₹4,207 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,476 Cr | 9.72 | |
| Mar2025 | ₹5,902 Cr | 14.00 | |
| Mar2024 | ₹5,178 Cr | 14.08 | |
| Mar2023 | ₹4,539 Cr | 7.88 | |
| Mar2022 | ₹4,207 Cr | - | |
Compare Total Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,348.7 Cr | 4.4% | -2.4% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,991.0 Cr | 1.1% | -4.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹256,310.0 Cr | 7.5% | 1.3% | 45.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,604.0 Cr | 1.8% | -6.3% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,722.0 Cr | 9.3% | 9.5% | 4.3% | Stock Analytics | |
| CIPLA | ₹109,628.0 Cr | 1.5% | -2.3% | -17.3% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 4.4% |
-2.4% |
-12.7% |
| SENSEX | 1.2% |
0.4% |
-12.2% |
You may also like the below Video Courses